Inhalation and Oral Studies of Ethyl Parathion Administered Acutely and Sub-Acutely to the Rat and Dog
Public Domain
File Language:
English
Details
-
Alternative Title:Parathion -- inhalation and oral toxicity studies on rats and dogs
-
Journal Article:National Institute for Occupational Safety and Health
-
Description:Acute and subacute oral and inhalation toxicity of ethyl parathion (56382) was studied in male Sprague-Dawley-rats crossed with Wistar-rats and male Beagle-dogs. Experimental animals received single acute or subacute doses administered over 6 weeks. Median lethal concentration (LC50) for rats in acute inhalation studies was 84.00 milligrams per cubic meter (mg/m3). The red blood cell (RBC) median cholinesterase activity inhibition concentration was 5.43mg/m3, and the plasma median cholinesterase activity inhibition concentration was 7.28mg/m3. Toxic signs included tremors, convulsions, salivation, respiratory difficulty, and death. Dogs were acutely exposed to concentrations ranging from 0.0153 to 37.13mg/m3. Cholinesterase activity was inhibited at all exposure concentrations. In acute oral studies, the LD50 for rats was 6.85mg/kilogram (kg), the RBC median cholinesterase activity inhibition concentration was 2.58mg/kg, and the plasma median cholinesterase activity inhibition concentration was 2.5mg/kg. Tremors, salivation, convulsions, prostration, and death were observed. In dogs, the acute oral LD50 was 8.27mg/kg, the RBC median cholinesterase activity inhibition concentration was 1.5mg/kg, and the plasma median cholinesterase inhibition activity concentration was 1.67mg/kg. Tremors, convulsions, and death were observed. In subacute inhalation studies, 0.01mg/m3 had no effects in rats, whereas doses of 0.10 and 0.74mg/m3 had moderate and pronounced effects, respectively. In dogs, 0.001mg/m3 subacute inhalation exposure had no effects, whereas 0.01 and 0.20mg/m3 had moderate and pronounced effects, respectively. In subacute oral toxicity tests the ethyl parathion concentrations producing no effect, moderate effects, and pronounced effects on RBC and plasma cholinesterase activity in rats were 0.05, 0.10, and 0.25mg/kg, respectively. The corresponding values in dogs were 0.05, 0.10, The authors suggest that human exposure levels can be predicted from observed effects on RBC or plasma cholinesterase activity. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
Publisher:
-
Document Type:
-
Genre:
-
Place as Subject:
-
CIO:
-
Topic:
-
Location:
-
Pages in Document:103 pdf pages
-
NIOSHTIC Number:nn:00134578
-
CAS Registry Number:
-
Federal Fiscal Year:1976
-
Performing Organization:
-
Peer Reviewed:False
-
Download URL:
-
File Type:
-
Collection(s):
-
Main Document Checksum:urn:sha-512:190099003dd806d46dd4d7b7d9ab660462cb842c397e43cb2ffc346d3eaa09bd56a1a39fe0d78a5f83b1d8a1beba71462474846d8bf34bbd77bdc3017b7cb0fc
File Language:
English
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings, journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like